From these clinicopathological analyses, we hypothesized that PKM2 might be related to EMT and play some crucial roles in the OSCC progression, and if so, PKM2 might be a useful clinical therapeutic target in addition to a potential biomarker representative of cancer cell activity or metastasis in OSCC. Here, PKM is linked to cancer.